# Using Gene Modified Neuroblastoma Cells for the Treatment of Relapsed/Refractory Neuroblastoma

> **NCT00062855** · PHASE1 · COMPLETED · sponsor: **Baylor College of Medicine** · enrollment: 9 (actual)

## Conditions studied

- Neuroblastoma

## Interventions

- **PROCEDURE:** Skin Biopsy
- **GENETIC:** Gene Modified Neuroblastoma Cells

## Key facts

- **NCT ID:** NCT00062855
- **Lead sponsor:** Baylor College of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-11
- **Primary completion:** 2001-08
- **Final completion:** 2006-03
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2012-10-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00062855

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00062855, "Using Gene Modified Neuroblastoma Cells for the Treatment of Relapsed/Refractory Neuroblastoma". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00062855. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*